🦠 Gameto Raises $44M Series C as Stem Cell Trial Enters Phase 3

The women-led startup will use the funding to advance preclinical development of its cervical barrier device toward first-in-human clinical studies.

"This is a defining moment for Gameto and for our broader mission of advancing women's and family health"

— Dr. Dina Radenkovic Turner, CEO & Co-Founder, Gameto

‍🔗 Read More

‍

💊 DITTO Daily Raises £1.35M for Science-based Menstrual Supplements

The pre-seed funding will be used to scale DITTO's science-led supplements targeting menstrual symptoms.

🔗 Read More

‍

🏥 Northern Ireland GP Platform Duality Healthcare Secures £4.5M to Support NHS

The funding will accelerate new clinics across the region, enable further development of the company’s digital healthcare infrastructure, and support the creation of up to 80 new jobs.

‍🔗 Read More

‍

🔬 Maven Launches Cycle Tracker and At-Home Male Fertility Testing

The cycle tracker will become available for Maven members in the Fertility and Family Building program this Autumn.

🔗 Read More

‍

❤️ $3M Gift Powers Women's Heart Health Research

This investment will provide huge amounts of support to the Go Red for Women® Venture Fund.

“The Shapiros’ generosity is nothing short of extraordinary and will support the Association’s work to change the future of health,”

— Nancy Brown, Chief Executive Officer, American Heart Association.

🔗 Read More

‍

🩺 UK Approves First Testosterone Cream for Postmenopausal Women

This means that women will be able to access the cream when the UK-approved version of the product becomes available in 2026.

🔗 Read More

‍

🔬 New At-Home Cervical Screening Wand Could Replace Pap Smears

The Teal Wand received FDA approval in May and is currently available in California.

🔗 Read More

‍

📱 AI App Ovum Empowers Australian Women to Take Control of Their Health

Officially launching on the App Store, Ovum is powered by an AI engine built to help women understand their body.

🔗 Read More

‍

💲Gates Foundation Have Announced They Are Committing $2.5B To Transform Women's Health

It will support the advancement of more than 40 innovations in five underfunded areas.

“This record investment will accelerate research and development across five critical, yet chronically underfunded areas, particularly affecting women in low- and middle-income countries,”

— Mark Suzman, CEO, Gates Foundation

🔗 Read More

‍

🧬 Imagion secures $3.5M to progress early cancer detection clinical trials

The company is currently preparing to enter Phase II trial for HER2+ breast cancer in the US.

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.  

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!